Mutation Analysis of the Transcription Factor PU.1 in Younger Adults (16 to 60 Years) With Acute Myeloid Leukemia: A Study of the AML Study Group Ulm (AMLSG ULM)

Blood - United States
doi 10.1182/blood-2003-08-2654
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Hematology

Related search

Rewiring of the Transcription Factor Network in Acute Myeloid Leukemia

Cancer Informatics
Cancer ResearchOncology
2019English

Phase I Study of Oral Clofarabine Consolidation in Adults Aged 60 and Older With Acute Myeloid Leukemia

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2013English

RAS Mutation in Acute Myeloid Leukemia Is Associated With Distinct Cytogenetic Subgroups but Does Not Influence Outcome in Patients Younger Than 60 Years

Blood
BiochemistryImmunologyCell BiologyHematology
2005English

Stuttgart-Ulm Rail Project / Bahnprojekt Stuttgart-Ulm

Geomechanik und Tunnelbau
CivilGeotechnical EngineeringEngineering GeologyStructural Engineering
2017English

Clofarabine, Idarubicin, and Cytarabine (CIA) as Frontline Therapy for Patients <= 60 Years With Newly Diagnosed Acute Myeloid Leukemia (AML)

Blood
BiochemistryImmunologyCell BiologyHematology
2012English

Comprehensive Molecular Landscape in Patients Older Than 80 Years Old Diagnosed With Acute Myeloid Leukemia: A Study of the French Hauts-De-France AML Observatory

American Journal of Hematology
Hematology
2018English

Phase 1 Study of the MDM2 Antagonist RO6839921 in Patients With Acute Myeloid Leukemia

Investigational New Drugs
OncologyPharmacology
2020English

Simpson's Paradox and the Impact of Different DNMT3A Mutations on Outcome in Younger Adults With Acute Myeloid Leukemia

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2015English

Cardiovascular Risk Factor Screening Satisfaction in the Heart of New Ulm Project

Clinical Medicine and Research
MedicineHome CareCommunity
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy